retatrutide side effects phase 2 trial study sees significant weight loss in obesity drug study Retatrutide for weight loss: Study

The clinical trials that established the efficacy of Wegovy and Zepbound did not require participants to follow structured exercise programs

Other GLP-1 medications, such as Wegovy, are approved specifically for weight loss

Published phase 2 trials for Retatrutide showed superior weight reduction compared to Tirzepatide, with subjects experiencing notable increases in resting metabolic rate

The appetite suppression is strong during this window, which paradoxically can help, you eat less, which means less food in the stomach to generate acid

What is the standard retatrutide dosing protocol

The Wegovy pill is an oral GLP1 medication taken once daily, while injectable Wegovy is administered weekly